CANAGLIFLOZIN FOR THE TREATMENT OF DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE

摘要

The present disclosure provides methods for treating chronic kidney disease, comprising administering to a patient in need thereof, a therapeutically effective amount of canagliflozin; wherein the patient is diagnosed with Type II diabetes mellitus.